Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online ahead of print on 23 April 2009 as doi:10.1099/mic.0.025726-0
Microbiology 2009;155:2353.

Microbiology (2009), DOI 10.1099/mic.0.025726-0
© 2009 Society for General Microbiology

This Article
Right arrow Full Text (Papers in Press[PDF])
Right arrow All Versions of this Article:
mic.0.025726-0v1
155/7/2353    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dharmasena, M. N
Right arrow Articles by Taylor, R. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dharmasena, M. N
Right arrow Articles by Taylor, R. K
Agricola
Right arrow Articles by Dharmasena, M. N
Right arrow Articles by Taylor, R. K
Microbiology 0 (2009), mic.0.025726; DOI  10.1099/mic.0.025726-0
© 2009 Society for General Microbiology


Characterization of a novel protective monoclonal antibody that recognises an epitope common to Vibrio cholerae Ogawa and Inaba serotypes

Madushini N Dharmasena, Shelly J Krebs and Ronald K Taylor1

Dartmouth Medical School

ABSTRACT

A novel protective monoclonal antibody (mAb) that recognises a lipopolysaccharide (LPS) epitope common between serotypes Ogawa and Inaba of the O1 serogroup of Vibrio cholerae was characterised and the potential to develop peptide mimics of this protective LPS epitope was investigated. MAb 72.1 recognises both Ogawa and Inaba LPS and it is vibriocidal and protective in passive immunization against infection by strains of both serotypes. The cDNA derived amino acid sequence of mAb 72.1 is closely related to the previously characterised mAb ZAC-3, which is thought to recognise an epitope in the lipid A-core region of O1 LPS. In an attempt to develop a peptide mimic based vaccine against V. cholerae, phage display libraries were screened with mAb 72.1 and eleven peptide mimics were identified. Remarkably, all of the peptide sequences identified from linear phage display libraries contained two cysteine residues suggesting that mAb 72.1 preferentially binds to peptides constrained with a disulphide bond. One of the peptide mimics was immunologically characterised. Although immunization of mice with this peptide mimic conjugated to KLH elicited Abs against the peptide itself, these Abs did not cross-react with Ogawa or Inaba LPS. Effectiveness of a peptide mimic as a vaccine may depend on how well the peptide can mimic the carbohydrate interactions when binding to the anti-carbohydrate Ab. Thus, investigating how peptides and LPS bind to mAb 72.1 may be useful in improving current peptide mimics or designing more effective peptide mimics. Identification and characterisation of novel protective anti-LPS Abs may be useful in studying protective epitopes of LPS which may help develop LPS based therapeutics against V. cholerae.

1 E-mail: ronald.k.taylor{at}dartmouth.edu







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2009 Society for General Microbiology.